Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Eligard 4 Month

Eligard 4 Month is a medicine containing the active ingredient(s) leuprorelin. On this page you will find out more about Eligard 4 Month, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: leuprorelin

Information for medicine and pack size:
Eligard 4 Month (1 x 30 mg syringe, 1 x diluent syringe), 1 pack

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Eligard is indicated for the: - Palliative treatment of advanced prostate cancer - Treatment of high-risk localised and locally advanced hormone-dependent prostate cancer in combination with radiotherapy

Table of characteristics
Table of characteristics
Active ingredient
Medicine schedule
1 injection, containing syringe A & syringe B.: Prescription Only Medicine, or Prescription Animal Remedy
Part 1
Part 1
Visual appearance Colourless to pale yellow clear viscous solution. May contain air bubbles but if free from visible particles and foreign matter.
Dosage Form Injection, modified release
Route of administration Subcutaneous
Part 2
Part 2
Visual appearance A white to off-white powder. Substantially free of foreign matter with no evidence of meltback.
Dosage Form Injection, modified release
Route of administration Subcutaneous

There is one type of pack available.

Pack type 1
Pack type 1
Type Syringe
Storage temperature Store below 8 degrees Celsius (refrigerate)
Storage conditions No information available
Life time 2 Years
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 May 2018

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo